Green Dot Bioplastics Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 18

Employees
  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Green Dot Bioplastics General Information

Description

Manufacturer of bioplastic products intended to offer a wide range of sustainable materials. The company's products include a full line of bioplastics and biocomposites used in footwear, textiles, home furnishings, electronics, pet supplies, lawn and garden, horticulture, and construction sectors, enabling brand-owners, plastics processors, and designers to avail near-term technology for biodegradable products and packaging that can reduce the use of petroleum-based plastics and eliminate plastic pollution.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Materials
Other Industries
Environmental Services (B2B)
Biotechnology
Primary Office
  • 527 Commercial
  • Suite 310
  • Emporia, KS 66801
  • United States
+1 (620) 000-0000

Green Dot Bioplastics Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Green Dot Bioplastics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 19-Apr-2022 000.00 Completed Generating Revenue
3. Later Stage VC (Series A2) 10-Nov-2021 00.000 000.00 000.00 Completed Generating Revenue
2. Debt - PPP 07-Apr-2020 $6.46M Completed Generating Revenue
1. Later Stage VC (Series A1) 07-Feb-2019 $6.46M $6.46M 000.00 Completed Generating Revenue
To view Green Dot Bioplastics’s complete valuation and funding history, request access »

Green Dot Bioplastics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 0.000
Series A-1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
To view Green Dot Bioplastics’s complete cap table history, request access »

Green Dot Bioplastics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of bioplastic products intended to offer a wide range of sustainable materials. The company's products incl
Other Materials
Emporia, KS
18 As of 2023
000.00
00000000000 000.00

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
00000 000000000
Carberry, Canada
0000000000

000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in r
00000 000000000
Idaho Falls, ID
00 As of 0000
000.00
000000000 - 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Green Dot Bioplastics Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solanyl Biopolymers Corporation Carberry, Canada 0000000000
00000000 Venture Capital-Backed Idaho Falls, ID 00 000.00 000000000 - 000.00
00000000000 000000 Accelerator/Incubator Backed Edmonton, Canada 00 00.00 0000000000 00.00
0000000000 0000000 Corporate Backed or Acquired Zurich, Switzerland 0000 000000&0
0000 00000 Venture Capital-Backed San Jose, CA 00 00.000 0000000000 0 00.000
You’re viewing 5 of 8 competitors. Get the full list »

Green Dot Bioplastics Patents

Green Dot Bioplastics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200291137-A1 Thermoplastic starch and method for preparing the same Active 15-Mar-2019 000000000
AU-2020241239-A1 Thermoplastic starch and method for preparing the same Pending 15-Mar-2019 000000000
EP-3938406-A1 Thermoplastic starch and method for preparing the same Pending 15-Mar-2019 000000000
EP-3938406-A4 Thermoplastic starch and method for preparing the same Pending 15-Mar-2019 000000000 0
US-11649297-B2 Thermoplastic starch and method for preparing the same Active 15-Mar-2019 C08B30/00 00
To view Green Dot Bioplastics’s complete patent history, request access »

Green Dot Bioplastics Executive Team (6)

Name Title Board Seat Contact Info
Mark Remmert Chief Executive Officer & Board Member
Kelvin Okamoto Ph.D Chief Technical Officer
Lydia Kinkade Advisor
Tom Doxsie Advisor
Duane Cantrell Chairman
You’re viewing 5 of 6 executive team members. Get the full list »

Green Dot Bioplastics Board Members (8)

Name Representing Role Since
Chris Edwards Green Dot Bioplastics Board Member 000 0000
Christian Zugel Green Dot Bioplastics Board Member 000 0000
Duane Cantrell Self Chairman 000 0000
Kevin Lockett Fulcrum Global Capital Advisor & Board Observer 000 0000
Mark Mahoney Self Co-Founder, Board Member & Advisor 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Green Dot Bioplastics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Green Dot Bioplastics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Fulcrum Global Capital Venture Capital Minority 000 0000 000000 0
iiM Venture Capital Minority 000 0000 000000 0
Open Prairie Ventures Asset Manager Minority 000 0000 000000 0
To view Green Dot Bioplastics’s complete investors history, request access »

Green Dot Bioplastics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 11-Feb-2013 0000000000 Other Commercial Products 0000 0000
To view Green Dot Bioplastics’s complete acquisitions history, request access »